SchenkLab Profile Banner
Erin Schenk, MD, PhD Profile
Erin Schenk, MD, PhD

@SchenkLab

Followers
620
Following
1K
Media
25
Statuses
222

Thoracic Med Onc | Scientist @CUAnschutz | My lab studies the interface between the immune system and lung cancer | Immunotherapy enthusiast | @MayoHemeOnc Alum

CU Anschutz Medical Center
Joined August 2019
Don't wanna be here? Send us removal request.
@SchenkLab
Erin Schenk, MD, PhD
7 months
Happy holidays from the Schenk Lab!
Tweet media one
0
1
22
@SchenkLab
Erin Schenk, MD, PhD
7 months
Thrilled to be part of the Lung TeamLab and the incredible collaboration to eliminate residual disease!.
@break_cancer
Break Through Cancer
7 months
Today we launch the PoweRD 2 Cure ALK+ Lung Cancer TeamLab! .Uniting researchers from @DanaFarber @MDAndersonNews @kochinstitute @KimmelCancerCtr @MSKCancerCenter @BostonChildrens @MGHCancerCenter @CUCancerCenter @VUMC_Cancer in radical collaboration to target residual lung
0
2
14
@SchenkLab
Erin Schenk, MD, PhD
1 year
The promise of immune-based therapies still needs to reach patients with NSCLC bearing driver alterations. We need to look beyond checkpoint inhibitors. Thank you @NarjustFlorezMD and @BiagioRicciutMD.for the amazing discussion! #LCSM.
@NarjustFlorezMD
Narjust Florez, MD, FASCO
1 year
I hope you are ready for this discussion with Drs. @SchenkLab & @BiagioRicciutMD . I learned SO much only in the first 5 minutes of this conversation about the use of IO in patients with NSCLC and driver mutations. Including .-Toxicity .-Importance of NGS.-Prognostic and
Tweet media one
1
4
19
@SchenkLab
Erin Schenk, MD, PhD
1 year
Don’t miss out! My colleague @TejasPatilMD presenting his exciting work on early MET bypass signaling in ALK and RET driven NSCLC. He is also an @CUCancerCenter Rising Star! @LUNGevity @ALKPositiveinc @RETpositive #LCSM #AACR24
Tweet media one
1
7
22
@SchenkLab
Erin Schenk, MD, PhD
1 year
@thehuffproject @LUNGevity @Joshua_Reuss my colleague in arms against lung cancer is doing amazing work to unravel who can benefit from IO/VEGF therapy in his IIT and is supported by @thehuffproject and @LUNGevity. Josh let's talk translation and upping my wall art game 😁.
0
0
1
@SchenkLab
Erin Schenk, MD, PhD
1 year
Thank you to @thehuffproject and @LUNGevity for supporting my career development award. Fantastic experience today sharing with @thehuffproject about the work my lab has been able to do #LCSM #ALKpositve
Tweet media one
2
6
33
@SchenkLab
Erin Schenk, MD, PhD
1 year
I am so grateful to have a forever friend that knew me when❤️.
@NarjustFlorezMD
Narjust Florez, MD, FASCO
1 year
@MayoHemeOnc gave me a thoracic oncology sister for life! . Dr. @SchenkLab . Fancy breakfast and soulful conversations. #TTLC24
Tweet media one
0
1
7
@SchenkLab
Erin Schenk, MD, PhD
1 year
RT @NarjustFlorezMD: @MayoHemeOnc gave me a thoracic oncology sister for life! . Dr. @SchenkLab . Fancy breakfast and soulful conversations….
0
1
0
@SchenkLab
Erin Schenk, MD, PhD
2 years
One of the best parts of this job is seeing your mentees succeed. Keep up the great work Patrick and Amaie (not pictured but proud to say he got into pharmacy school!). Hearing from both made my day
Tweet media one
1
0
21
@SchenkLab
Erin Schenk, MD, PhD
2 years
Just submitted a large external grant. Because I care about my #worklifebalance, I'm going to give myself 15 hours off before starting on the next grant🙃🤣 #science #PILife #ButIStillLoveIt.
0
0
21
@SchenkLab
Erin Schenk, MD, PhD
2 years
Thank you @ALKPositiveinc! Currently in the lab working towards new plans.
@ALKPositiveinc
ALK Positive
2 years
ALK+ #lungcancer patients like having plans A, B and C all lined up. #Research helps us do this. Ultimately, as Dr Erin Schenk of @SchenkLab says, research helps us do better for our patients not only today… but tomorrow. It's really about #MoreResearchMoreLife . #LCAM
Tweet media one
1
0
19
@SchenkLab
Erin Schenk, MD, PhD
2 years
I often share the words of a mentor/hero of mine (a hematologist) in my clinical practice as a thoracic oncologist:. “It is better to start the right treatment rather than the fast one.”.
@StephenVLiu
Stephen V Liu, MD
2 years
More data showing the importance of *waiting* for NGS results before starting NSCLC therapy whenever possible!. Retrospective analysis @JCOOP_ASCO show that when treatment of driver+ NSCLC before biomarker results is associated with inferior survival.
Tweet media one
0
0
17
@SchenkLab
Erin Schenk, MD, PhD
2 years
Thank you for the invitation to speak! One day would love to be part of a session focused on novel immune approaches for EGFR/ALK/ROS1. Cell therapies, BiTEs, macrophage check points….
@KE_Gallaway
Kathryn Gallaway, MD
2 years
Fascinating lecture describing how the interaction between tumor cells and macrophages in the TME can drive resistance to targeted therapies. Looking forward to future work from @SchenkLab in this space! #DAVAHawaiiLung
Tweet media one
Tweet media two
2
2
16
@SchenkLab
Erin Schenk, MD, PhD
2 years
Amazing fact about science: there are always new and different ways something can go wrong. Luckily our new problem was easily solved. Onward! #labdaydiaries #keepmovingforward.
0
0
2
@SchenkLab
Erin Schenk, MD, PhD
2 years
Highly recommend! The MBCO AACR course was an incredible opportunity to meet with other physician scientists, discuss opportunities and challenges unique to this path. Thank you @christine_lovly for encouraging me to apply.
@christine_lovly
Christine Lovly, MD, PhD, FASCO
2 years
Tagging some of the many amazing people I have met at the @AACR MBCO course: @DrBetofMDPhD @juanosoriomd @BZhangMD @SchenkLab @josephcmurray @catherine_fahey @cnebhan @jmchan88, @JenWargoMD, @carlhjune. Please spread the word about the course!
Tweet media one
0
2
11
@SchenkLab
Erin Schenk, MD, PhD
2 years
Goodbye TTLC! It was so nice to see you again #TTLC23 .Looking forward to TTLC24!.
0
0
9
@SchenkLab
Erin Schenk, MD, PhD
2 years
RT @TejasPatilMD: Just out!! Congrats to CU Rad Onc and @BK_radiation. CNS downstaging continues to evolve. For pts with extensive brain me….
0
6
0
@SchenkLab
Erin Schenk, MD, PhD
2 years
0
3
3
@SchenkLab
Erin Schenk, MD, PhD
2 years
Congratulations to Schenk Lab Emerita Katie Priest for her work unraveling how an evolving KRAS G12C+ clone interfered with a ROS1 TKI response. Thank you to collaborators on Twitter @DLApathologist @rdoebele and @LUNGevity and @ros1cancer for support!.
1
2
12
@SchenkLab
Erin Schenk, MD, PhD
3 years
It's 230 pm - a perfect time to write my budget justification jamming to GnR Sweet Child O' Mine. Where do we go? .Where do these costs go?.Where do they go?.
0
0
6